Allianz’s Labcorp LH Stock Holding History

Allianz’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-63	Closed	-$14.7K	–	423
2025 Q1	$14.7K	Hold	63	–	–	﹤0.01%	384
2024 Q4	$14.4K	Sell	63 -137	-69%	-$31.4K	﹤0.01%	399
2024 Q3	$44.7K	Sell	200 -720	-78%	-$158K	﹤0.01%	348
2024 Q2	$187K	Buy	+920	New	+$187K	0.01%	331

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz's LH Position: Q2 2025 in Review

Allianz sold out of Labcorp (LH) in Q2 2025, closing a stake of 63 shares — an estimated $14.7K sold.

Allianz first reported a position in LH in Q2 2024 and held it in 4 quarters. The position peaked at $187K in Q2 2024. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

Allianz reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
Allianz sold 63 Labcorp shares in Q2 2025, an estimated $14.7K.
Allianz first reported a position in Labcorp in Q2 2024 and held it in 4 quarters.
Allianz's Labcorp position peaked at $187K in Q2 2024.
973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Allianz's 13F filing for Q2 2025, filed 8 Aug 2025.